Growth Metrics

Solid Biosciences (SLDB) Net Cash Flow (2017 - 2026)

Quarterly results put Net Cash Flow at $236.6 million for Q1 2026, up 81.39% from a year ago — trailing twelve months through Mar 2026 was $85.8 million (down 7.89% YoY), and the annual figure for FY2025 was -$20.3 million, down 420.19%.

Solid Biosciences has reported Net Cash Flow over the past 10 years, most recently at $236.6 million for Q1 2026.

  • Net Cash Flow reached $236.6 million in Q1 2026 per SLDB's latest filing, up from -$1.4 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $236.6 million in Q1 2026 and bottomed at -$77.6 million in Q3 2025.
  • Median Net Cash Flow over the past 5 years was -$1.4 million (2025), compared with a mean of $10.3 million.
  • The largest annual shift saw Net Cash Flow soared 1035.32% in 2022 before it tumbled 670.37% in 2023.
  • Over 5 years, Net Cash Flow stood at $106.4 million in 2022, then plummeted by 76.51% to $25.0 million in 2023, then plummeted by 36.5% to $15.9 million in 2024, then tumbled by 108.81% to -$1.4 million in 2025, then surged by 17020.96% to $236.6 million in 2026.
  • Business Quant data shows Net Cash Flow for SLDB at $236.6 million in Q1 2026, -$1.4 million in Q4 2025, and -$77.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 2.44 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 625.70 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -2.44 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 457.40 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -152.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 60.68 Mn
10 Solid Biosciences 713.77 Mn 333.09 Mn - 236.56 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 236.56 Mn
Mar 31, 2026 236.56 Mn
Dec 31, 2025 -1.40 Mn
Dec 31, 2025 -1.40 Mn
Sep 30, 2025 -77.57 Mn
Sep 30, 2025 -77.57 Mn
Jun 30, 2025 -71.75 Mn
Jun 30, 2025 -71.75 Mn
Mar 31, 2025 130.42 Mn
Mar 31, 2025 130.42 Mn
Dec 31, 2024 15.86 Mn
Dec 31, 2024 15.86 Mn
Sep 30, 2024 -31.44 Mn
Sep 30, 2024 -31.44 Mn
Jun 30, 2024 -21.64 Mn
Jun 30, 2024 -21.64 Mn
Mar 31, 2024 43.56 Mn
Mar 31, 2024 43.56 Mn
Dec 31, 2023 24.98 Mn
Dec 31, 2023 24.98 Mn
Sep 30, 2023 -42.53 Mn
Sep 30, 2023 -42.53 Mn
Jun 30, 2023 -75.70 Mn
Jun 30, 2023 -75.70 Mn
Mar 31, 2023 9.27 Mn
Mar 31, 2023 9.27 Mn
Dec 31, 2022 106.36 Mn
Dec 31, 2022 106.36 Mn
Sep 30, 2022 -5.52 Mn
Sep 30, 2022 -5.52 Mn
Jun 30, 2022 -75.40 Mn
Jun 30, 2022 -75.40 Mn
Mar 31, 2022 10.58 Mn
Mar 31, 2022 10.58 Mn
Dec 31, 2021 9.37 Mn
Dec 31, 2021 9.37 Mn
Sep 30, 2021 -90.93 Mn
Sep 30, 2021 -90.93 Mn
Jun 30, 2021 -66.06 Mn
Jun 30, 2021 -66.06 Mn
Mar 31, 2021 113.75 Mn
Mar 31, 2021 113.75 Mn
Dec 31, 2020 1.25 Mn
Dec 31, 2020 1.25 Mn
Sep 30, 2020 -15.64 Mn
Sep 30, 2020 -15.64 Mn
Jun 30, 2020 -12.75 Mn
Jun 30, 2020 -12.75 Mn
Mar 31, 2020 -22.86 Mn
Mar 31, 2020 -22.86 Mn
Dec 31, 2019 -18.68 Mn
Dec 31, 2019 -18.68 Mn
Sep 30, 2019 -15.28 Mn
Sep 30, 2019 -15.28 Mn
Jun 30, 2019 -2.16 Mn
Jun 30, 2019 -2.16 Mn
Mar 31, 2019 -32.37 Mn
Mar 31, 2019 -32.37 Mn
Dec 31, 2018 -42.68 Mn
Dec 31, 2018 -42.68 Mn
Sep 30, 2018 -16.69 Mn
Sep 30, 2018 -16.69 Mn
Jun 30, 2018 -19.01 Mn
Jun 30, 2018 -19.01 Mn
Mar 31, 2018 112.93 Mn
Mar 31, 2018 112.93 Mn
Dec 31, 2017 36.97 Mn
Dec 31, 2017 36.97 Mn
Sep 30, 2017 -17.70 Mn
Sep 30, 2017 -17.70 Mn
Jun 30, 2017 3.45 Mn
Jun 30, 2017 3.45 Mn
Mar 31, 2017 21.59 Mn
Mar 31, 2017 21.59 Mn